Grove Bank & Trust’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Buy |
4,999
+945
| +23% | +$261K | 0.11% | 110 |
|
|
2026
Q1 | $1.2M | Sell |
4,054
-206
| -5% | -$61.2K | 0.14% | 96 |
|
|
2025
Q4 | $1.16M | Buy |
4,260
+773
| +22% | +$210K | 0.13% | 103 |
|
|
2025
Q3 | $942K | Sell |
3,487
-199
| -5% | -$54.1K | 0.11% | 116 |
|
|
2025
Q2 | $1.02M | Sell |
3,686
-1,077
| -23% | -$293K | 0.13% | 108 |
|
|
2025
Q1 | $1.26M | Buy |
4,763
+127
| +3% | +$31.3K | 0.17% | 92 |
|
|
2024
Q4 | $1.08M | Buy |
4,636
+360
| +8% | +$82.8K | 0.15% | 96 |
|
|
2024
Q3 | $943K | Buy |
4,276
+55
| +1% | +$11.4K | 0.14% | 98 |
|
|
2024
Q2 | $830K | Buy |
4,221
+731
| +21% | +$151K | 0.13% | 102 |
|
|
2024
Q1 | $751K | Buy |
3,490
+2,199
| +170% | +$462K | 0.13% | 106 |
|
|
2023
Q4 | $272K | Sell |
1,291
-9
| -0.7% | -$1.92K | 0.05% | 191 |
|
|
2023
Q3 | $260K | Buy |
1,300
+107
| +9% | +$21.3K | 0.05% | 188 |
|
|
2023
Q2 | $221K | Sell |
1,193
-77
| -6% | -$14.2K | 0.04% | 204 |
|
|
2023
Q1 | $243K | Sell |
1,270
-22
| -2% | -$3.98K | 0.05% | 192 |
|
|
2022
Q4 | $217K | Buy |
1,292
+36
| +3% | +$6.26K | 0.05% | 205 |
|
|
2022
Q3 | $222K | Buy |
1,256
+14
| +1% | +$2.77K | 0.06% | 194 |
|
|
2022
Q2 | $254K | Sell |
1,242
-437
| -26% | -$92.6K | 0.06% | 186 |
|
|
2022
Q1 | $399K | Buy |
1,679
+220
| +15% | +$51.7K | 0.08% | 165 |
|
|
2021
Q4 | $333K | Hold |
1,459
| – | – | 0.06% | 188 |
|
|
2021
Q3 | $282K | Hold |
1,459
| – | – | 0.06% | 193 |
|
|
2021
Q2 | $310K | Hold |
1,459
| – | – | 0.07% | 179 |
|
|
2021
Q1 | $298K | Sell |
1,459
-18
| -1% | -$3.54K | 0.07% | 176 |
|
|
2020
Q4 | $269K | Buy |
1,477
+244
| +20% | +$41.5K | 0.07% | 170 |
|
|
2020
Q3 | $206K | Sell |
1,233
-134
| -10% | -$22.6K | 0.06% | 173 |
|
|
2020
Q2 | $222K | Sell |
1,367
-81
| -6% | -$14.5K | 0.07% | 166 |
|
|
2020
Q1 | $250K | Sell |
1,448
-117
| -7% | -$23.3K | 0.1% | 145 |
|
|
2019
Q4 | $314K | Buy |
1,565
+57
| +4% | +$11.7K | 0.09% | 151 |
|
|
2019
Q3 | $319K | Buy |
+1,508
| New | +$315K | 0.1% | 147 |
|
|
2018
Q1 | – | Sell |
-793
| Closed | -$116K | – | 220 |
|
|
2017
Q4 | $116K | Sell |
793
-205
| -21% | -$29.2K | 0.05% | 209 |
|
|
2017
Q3 | $135K | Sell |
998
-276
| -22% | -$34.9K | 0.07% | 195 |
|
|
2017
Q2 | $160K | Buy |
1,274
+374
| +42% | +$44.7K | 0.1% | 150 |
|
|
2017
Q1 | $107K | Buy |
900
+440
| +96% | +$52.9K | 0.09% | 158 |
|
|
2016
Q4 | $53K | Buy |
+460
| New | +$51.2K | 0.04% | 206 |
|
Other funds holding CME
Grove Bank & Trust's CME Position: Q2 2026 in Review
Grove Bank & Trust increased its CME Group (CME) stake by 23% in Q2 2026, buying an estimated $261K and bringing the position to 4,999 shares worth $1.1M. The position accounts for 0.11% of the portfolio, ranked #110.
Grove Bank & Trust first reported a position in CME in Q4 2016 and has held it in 33 quarters since. The position peaked at $1.26M in Q1 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Grove Bank & Trust held 4,999 shares of CME Group worth $1.1M as of Q2 2026.
- Grove Bank & Trust bought 945 CME Group shares in Q2 2026, an estimated $261K.
- CME Group made up 0.11% of Grove Bank & Trust's portfolio in Q2 2026, its #110 holding.
- Grove Bank & Trust first reported a position in CME Group in Q4 2016 and has held it in 33 quarters since.
- Grove Bank & Trust's CME Group position peaked at $1.26M in Q1 2025.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.